8-K

Company

Elicio Therapeutics, Inc.

Filed

December 12, 2024

Period of Report

December 12, 2024

Accession Number

0001601485-24-000107

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →